The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance

被引:347
作者
Rinella, ME
Green, RM
机构
[1] Northwestern Univ, Feinberg Sch Med, Div Hepatol, Chicago, IL 60611 USA
[2] Div Gastroenterol & Hepatol, Chicago, IL 60611 USA
[3] Lakeside Vet Adm Med Ctr, Chicago, IL 60611 USA
关键词
alanine transaminase; steatohepatitis; non-alcoholic steatohepatitis; glucose; insulin resistance; quantitative insulin sensitivity check index; liver;
D O I
10.1016/j.jhep.2003.09.020
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Aims: Non-alcoholic steatohepatitis is an important disease whose pathophysiology remains incompletely understood, although in humans a strong association with insulin resistance exists. Mice fed a methionine-choline deficient (MCD) diet develop steatohepatitis, however the influence of insulin in this model is unknown. Methods: Male FVB/NJ mice were fed the MCD, MCD control or chow diet for 10 or 28 days. Fasting glucose, ALT, triglyceride and insulin was measured. Glucose tolerance tests (GTT) and insulin tolerance tests (ITT) were performed followed by quantitative insulin sensitivity check index (QUICKI) determination. Results: ALT levels were significantly higher in the MCD group. Fasting glucose was 81 +/- 5 mg/dl in MCD diet fed mice, compared to MCD controls (196 +/- 46 mg/dl) and chow (199 +/- 15 mg/dl) (P < 0.0001). During GTT and ITT, the effect of glucose administration on blood glucose was dampened, and the insulin effect more pronounced in the MCD group (P = 0.026 and P < 0.001). QUICKI in MCD fed mice was significantly higher than in the chow fed mice. Conclusions: GTT, ITT and QUICKI confirmed the absence of insulin resistance in the MCD fed mice. This model causes fibrosing steatohepatitis and may help delineate the non-insulin resistant mechanisms involved in human steatohepatitis. (C) 2003 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:47 / 51
页数:5
相关论文
共 31 条
[21]   Nonalcoholic steatosis and steatohepatitis -: III.: Peroxisomal β-oxidation, PPARα, and steatohepatitis [J].
Reddy, JK .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2001, 281 (06) :G1333-G1339
[22]  
Robertson Graham, 2001, American Journal of Physiology, V281, pG1135
[23]   QUANTITATION OF HEPATIC GLYCOGENOLYSIS AND GLUCONEOGENESIS IN FASTING HUMANS WITH C-13 NMR [J].
ROTHMAN, DL ;
MAGNUSSON, I ;
KATZ, LD ;
SHULMAN, RG ;
SHULMAN, GI .
SCIENCE, 1991, 254 (5031) :573-576
[24]   Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities [J].
Sanyal, AJ ;
Campbell-Sargent, C ;
Mirshahi, F ;
Rizzo, WB ;
Contos, MJ ;
Sterling, RK ;
Luketic, VA ;
Shiffman, ML ;
Clore, JN .
GASTROENTEROLOGY, 2001, 120 (05) :1183-1192
[25]   Leptin in hepatic fibrosis:: Evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice [J].
Saxena, NK ;
Ikeda, K ;
Rockey, DC ;
Friedman, SL ;
Anania, FA .
HEPATOLOGY, 2002, 35 (04) :762-771
[26]   Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology [J].
Skelly, MM ;
James, PD ;
Ryder, SD .
JOURNAL OF HEPATOLOGY, 2001, 35 (02) :195-199
[27]   The natural history of nonalcoholic fatty liver: A follow-up study [J].
Teli, MR ;
James, OFW ;
Burt, AD ;
Bennett, MK ;
Day, CP .
HEPATOLOGY, 1995, 22 (06) :1714-1719
[28]   Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function [J].
Uysal, KT ;
Wiesbrock, SM ;
Marino, MW ;
Hotamisligil, GS .
NATURE, 1997, 389 (6651) :610-614
[29]   Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation [J].
Weltman, MD ;
Farrell, GC ;
Liddle, C .
GASTROENTEROLOGY, 1996, 111 (06) :1645-1653
[30]   Hepatic cytochrome p450 2E1 is increased in patients with nonalcoholic steatohepatitis [J].
Weltman, MD ;
Farrell, GC ;
Hall, P ;
Ingelman-Sundberg, M ;
Liddle, C .
HEPATOLOGY, 1998, 27 (01) :128-133